Literature DB >> 21872631

Human leukocyte antigen associations with humoral and cellular immunity following a second dose of measles-containing vaccine: persistence, dampening, and extinction of associations found after a first dose.

Robert M Jacobson1, Inna G Ovsyannikova, Robert A Vierkant, V Shane Pankratz, Gregory A Poland.   

Abstract

Previously we found human leukocyte antigen (HLA) associations with humoral immunity following a single dose of measles-containing vaccine. In this study, we sought to determine if HLA associations exist with humoral and cellular immunity following a second dose of measles-containing vaccine and if the associations we found with humoral immunity after the first dose persist following a second dose. We recruited a population-based sample of 346 schoolchildren, all who previously received two doses of a measles-containing vaccine. Molecular HLA classes I and II typing as well as humoral and cellular immune assays (measles-specific IgG antibody levels and lymphoproliferative response) were performed in these subjects. We found significant associations with class I HLA-B (p=0.05) as well as class II HLA-DPB1 (p=0.01) and -DPA1 (p=0.03) genes for measles vaccine-induced antibody levels after the second dose. Similarly, we found significant associations with class II HLA-DQB1 (p=0.05) and -DRB1 (p=0.01) genes for measles-specific lymphoproliferation after the second dose. While we found HLA associations after the second dose that we previously found after the first dose of measles containing vaccine, fewer alleles had statistically significant associations, suggesting that the second dose had a dampening or extinguishing effect on the HLA associations. It appears that the second dose overcomes HLA restriction through an as yet unknown mechanism. Future studies of HLA associations should consider both the effect of dose and the role that subsequent doses might play on genetic associations found with the response to a first dose.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21872631      PMCID: PMC3319093          DOI: 10.1016/j.vaccine.2011.08.060

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  31 in total

Review 1.  Innovative bioinformatic approaches for developing peptide-based vaccines against hypervariable viruses.

Authors:  Danylo Sirskyj; Francisco Diaz-Mitoma; Ashkan Golshani; Ashok Kumar; Ali Azizi
Journal:  Immunol Cell Biol       Date:  2010-05-11       Impact factor: 5.126

2.  Performing the exact test of Hardy-Weinberg proportion for multiple alleles.

Authors:  S W Guo; E A Thompson
Journal:  Biometrics       Date:  1992-06       Impact factor: 2.571

Review 3.  Designing the next generation of vaccines for global public health.

Authors:  Fabio Bagnoli; Barbara Baudner; Ravi P N Mishra; Erika Bartolini; Luigi Fiaschi; Paolo Mariotti; Vincenzo Nardi-Dei; Phil Boucher; Rino Rappuoli
Journal:  OMICS       Date:  2011-06-17

Review 4.  Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections.

Authors:  Gregory A Poland; Inna G Ovsyannikova; Richard B Kennedy; Iana H Haralambieva; Robert M Jacobson
Journal:  OMICS       Date:  2011-07-06

5.  Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine.

Authors:  Inna G Ovsyannikova; V Shane Pankratz; Robert A Vierkant; Robert M Jacobson; Gregory A Poland
Journal:  J Infect Dis       Date:  2006-01-27       Impact factor: 5.226

6.  Human leukocyte antigen and interleukin 2, 10 and 12p40 cytokine responses to measles: is there evidence of the HLA effect?

Authors:  Inna G Ovsyannikova; Jenna E Ryan; Robert M Jacobson; Robert A Vierkant; V Shane Pankratz; Gregory A Poland
Journal:  Cytokine       Date:  2007-01-17       Impact factor: 3.861

Review 7.  Application of pharmacogenomics to vaccines.

Authors:  Gregory A Poland; Inna G Ovsyannikova; Robert M Jacobson
Journal:  Pharmacogenomics       Date:  2009-05       Impact factor: 2.533

Review 8.  Vaccine immunogenetics: bedside to bench to population.

Authors:  Gregory A Poland; Inna G Ovsyannikova; Robert M Jacobson
Journal:  Vaccine       Date:  2008-07-01       Impact factor: 3.641

9.  Next generation of human vaccines: what does the future hold?

Authors:  Sita Awasthi
Journal:  Hum Vaccin       Date:  2008-09-02

Review 10.  Personalized vaccines: the emerging field of vaccinomics.

Authors:  Gregory A Poland; Inna G Ovsyannikova; Robert M Jacobson
Journal:  Expert Opin Biol Ther       Date:  2008-11       Impact factor: 4.388

View more
  10 in total

1.  Consistency of HLA associations between two independent measles vaccine cohorts: a replication study.

Authors:  Inna G Ovsyannikova; V Shane Pankratz; Robert A Vierkant; Robert M Jacobson; Gregory A Poland
Journal:  Vaccine       Date:  2012-01-25       Impact factor: 3.641

Review 2.  Searching for the human genetic factors standing in the way of universally effective vaccines.

Authors:  Alexander J Mentzer; Daniel O'Connor; Andrew J Pollard; Adrian V S Hill
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-06-19       Impact factor: 6.237

3.  Polymorphisms in HLA-DPB1 are associated with differences in rubella virus-specific humoral immunity after vaccination.

Authors:  Nathaniel D Lambert; Iana H Haralambieva; Richard B Kennedy; Inna G Ovsyannikova; Vernon Shane Pankratz; Gregory A Poland
Journal:  J Infect Dis       Date:  2014-10-06       Impact factor: 5.226

Review 4.  The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; V Shane Pankratz; Richard B Kennedy; Robert M Jacobson; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2013-01       Impact factor: 5.217

Review 5.  Variability in Humoral Immunity to Measles Vaccine: New Developments.

Authors:  Iana H Haralambieva; Richard B Kennedy; Inna G Ovsyannikova; Jennifer A Whitaker; Gregory A Poland
Journal:  Trends Mol Med       Date:  2015-11-18       Impact factor: 11.951

6.  Human leukocyte antigens and cellular immune responses to anthrax vaccine adsorbed.

Authors:  Inna G Ovsyannikova; V Shane Pankratz; Robert A Vierkant; Nicholas M Pajewski; Conrad P Quinn; Richard A Kaslow; Robert M Jacobson; Gregory A Poland
Journal:  Infect Immun       Date:  2013-05-06       Impact factor: 3.441

7.  HLA-DR specific monoclonal antibodies block lymphoproliferative response to measles vaccine in vitro: a pilot study.

Authors:  David M Phelan; Gregory A Poland
Journal:  Vaccine       Date:  2012-08-31       Impact factor: 3.641

Review 8.  Immunological assessment of influenza vaccines and immune correlates of protection.

Authors:  Adrian Reber; Jacqueline Katz
Journal:  Expert Rev Vaccines       Date:  2013-05       Impact factor: 5.217

9.  Comprehensive Analysis of the Naturally Processed Peptide Repertoire: Differences between HLA-A and B in the Immunopeptidome.

Authors:  Ingrid M M Schellens; Ilka Hoof; Hugo D Meiring; Sanne N M Spijkers; Martien C M Poelen; Jacqueline A M van Gaans-van den Brink; Kees van der Poel; Ana I Costa; Cecile A C M van Els; Debbie van Baarle; Can Kesmir
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

Review 10.  Host genetics and infectious disease: new tools, insights and translational opportunities.

Authors:  Andrew J Kwok; Alex Mentzer; Julian C Knight
Journal:  Nat Rev Genet       Date:  2020-12-04       Impact factor: 53.242

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.